SCHEMBL4299301

SCHEMBL4299301

CN1CCCN(C(=O)Nc2cc(Cl)ccc2O)CC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.59
KMT2A Q03164 3/20 0.52
HRH4 Q9H3N8 2/20 0.51
ALDH1A1 P00352 3/20 0.48
RAB9A P51151 1/20 0.48
MEN1 O00255 2/20 0.47
KCNT1 Q5JUK3 1/20 0.47
RBP4 P02753 2/20 0.46
KDM4E B2RXH2 2/20 0.46
LMNA P02545 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
HSD17B10 Q99714 1/20 0.46
RECQL P46063 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
TP53 P04637 1/20 0.46
ALOX15 P16050 1/20 0.46
TSHR P16473 1/20 0.46
MAPK1 P28482 1/20 0.46
POLB P06746 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4307428 0.95 MAPT (0.57) MAPTKMT2AHRH4ALDH1A1MEN1
SCHEMBL4301167 0.84 MAPT (0.67) MAPTALDH1A1KCNT1RBP4KDM4E
SCHEMBL4299031 0.81 KDM4E (0.60) MAPTKMT2AALDH1A1MEN1KDM4E
SCHEMBL14372216 0.79 MEN1 (0.57) MAPTKMT2AHRH4ALDH1A1RAB9A
SCHEMBL4306285 0.78 KMT2A (0.77) MAPTKMT2AALDH1A1RAB9AMEN1
SCHEMBL4306582 0.78 MAPT (0.73) MAPTKMT2AMEN1KCNT1RBP4
SCHEMBL5462589 0.77 HRH4 (0.54) MAPTKMT2AHRH4ALDH1A1MEN1
SCHEMBL4300543 0.77 MAPT (0.74) MAPTKMT2AHRH4ALDH1A1RAB9A
SCHEMBL4299291 0.75 KDM4E (0.67) MAPTKMT2AALDH1A1MEN1KDM4E
SCHEMBL10691992 0.74 MAPT (0.49) MAPTKMT2AHRH4MEN1RBP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090118303-A1 SEROTONIN 5-HT3 RECEPTOR AGONIST RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2009-05-07 US disclosed
US-7485646-B2 Serotonin 5-HT3 receptor agonist RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2009-02-03 US disclosed
US-20070265277-A1 Serotonin 5-Ht3 Receptor Agonist RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2007-11-15 US disclosed
EP-1798227-A1 SEROTONIN 5-HT3 RECEPTOR AGONIST Research Foundation Itsuu Laboratory (JP) 2007-06-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118303-A1 SEROTONIN 5-HT3 RECEPTOR AGONIST HTR3A, HTR7, HTR1A MAPT 4268/4885KMT2A 3181/4885HRH4 90/4885
US-20070265277-A1 Serotonin 5-Ht3 Receptor Agonist HTR3A, HTR7, HTR1A MAPT 4268/4885KMT2A 3181/4885HRH4 90/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.